A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein.
about
CSPG4: a prototype oncoantigen for translational immunotherapy studies.Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand.Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types.Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast display.CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL.Human MAP Tau Based Targeted Cytolytic Fusion Proteins.Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation.Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells.
P2860
Q33862585-C92DEF8F-4F9E-420B-B9AD-8B1FE953F7BBQ40602973-BDB77503-7071-4A8B-87B5-1EB87F63C841Q47555734-D1417918-4880-4A7E-A122-28BC258CD67FQ47692413-9A541CEA-61C1-4A3F-9DAB-DC6407ABBC2FQ50918966-F0467AAB-D596-481A-BBAC-1AB6D537A4A2Q50921086-0B5F1F66-5BE1-4C1E-BA0F-04AF1DCCDBAEQ50985152-371DB617-DDDE-4923-B84D-FFE0F9AB97B3Q54261268-60F3C1E0-A28A-435F-A393-783786B5FD16
P2860
A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A novel approach for targeted ...... MAP tau-based fusion protein.
@en
type
label
A novel approach for targeted ...... MAP tau-based fusion protein.
@en
prefLabel
A novel approach for targeted ...... MAP tau-based fusion protein.
@en
P2093
P2860
P356
P1476
A novel approach for targeted ...... a MAP tau-based fusion protein
@en
P2093
Ahmad F Hussain
Alessa Pardo
Anh-Tuan Pham
Dmitrij Hristodorov
Fabian Kiessling
Katharina Kolberg
Manal Amoury
Michael Schwenkert
Radoslav Mladenov
P2860
P304
P356
10.1002/IJC.30119
P50
P577
2016-04-15T00:00:00Z